BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu Z, Long Y, Cun X, Wang X, Li J, Mei L, Yang Y, Li M, Zhang Z, He Q. A size-shrinkable nanoparticle-based combined anti-tumor and anti-inflammatory strategy for enhanced cancer therapy. Nanoscale 2018;10:9957-70. [PMID: 29770821 DOI: 10.1039/c8nr01184b] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Samuel SM, Varghese E, Kubatka P, Triggle CR, Büsselberg D. Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer. Biomolecules 2019;9:E846. [PMID: 31835318 DOI: 10.3390/biom9120846] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
2 Drozdov AS, Nikitin PI, Rozenberg JM. Systematic Review of Cancer Targeting by Nanoparticles Revealed a Global Association between Accumulation in Tumors and Spleen. Int J Mol Sci 2021;22:13011. [PMID: 34884816 DOI: 10.3390/ijms222313011] [Reference Citation Analysis]
3 Yoo J, Park C, Yi G, Lee D, Koo H. Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems. Cancers (Basel) 2019;11:E640. [PMID: 31072061 DOI: 10.3390/cancers11050640] [Cited by in Crossref: 152] [Cited by in F6Publishing: 112] [Article Influence: 50.7] [Reference Citation Analysis]
4 Li Y, Luan C. PLCE1 Promotes the Invasion and Migration of Esophageal Cancer Cells by Up-Regulating the PKCα/NF-κB Pathway. Yonsei Med J 2018;59:1159-65. [PMID: 30450849 DOI: 10.3349/ymj.2018.59.10.1159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
5 Capozza M, Anemone A, Dhakan C, Della Peruta M, Bracesco M, Zullino S, Villano D, Terreno E, Longo DL, Aime S. GlucoCEST MRI for the Evaluation Response to Chemotherapeutic and Metabolic Treatments in a Murine Triple-Negative Breast Cancer: A Comparison with[18F]F-FDG-PET. Mol Imaging Biol 2021. [PMID: 34383241 DOI: 10.1007/s11307-021-01637-6] [Reference Citation Analysis]
6 Chen Z, Wang W, Li Y, Wei C, Zhong P, He D, Liu H, Wang P, Huang Z, Zhu W, Zhou Y, Qin L. Folic Acid-Modified Erythrocyte Membrane Loading Dual Drug for Targeted and Chemo-Photothermal Synergistic Cancer Therapy. Mol Pharm 2021;18:386-402. [PMID: 33296217 DOI: 10.1021/acs.molpharmaceut.0c01008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Yang L, Zhao L, Zeng T, Chen H, Shao J, Yang S, Tao Z, Yang J, Chen T, Lin X, Chen X, Tang M. Mechanisms Underlying Therapeutic Effects Of Traditional Chinese Medicine On Gastric Cancer. Cancer Manag Res 2019;11:8407-18. [PMID: 31571996 DOI: 10.2147/CMAR.S218214] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
8 Al-Jameel SS, Almessiere MA, Khan FA, Taskhandi N, Slimani Y, Al-Saleh NS, Manikandan A, Al-Suhaimi EA, Baykal A. Synthesis, Characterization, Anti-Cancer Analysis of Sr0.5Ba0.5DyxSmxFe8-2xO19 (0.00 ≤ x ≤ 1.0) Microsphere Nanocomposites. Nanomaterials (Basel) 2021;11:700. [PMID: 33799552 DOI: 10.3390/nano11030700] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Rastegari E, Hsiao YJ, Lai WY, Lai YH, Yang TC, Chen SJ, Huang PI, Chiou SH, Mou CY, Chien Y. An Update on Mesoporous Silica Nanoparticle Applications in Nanomedicine. Pharmaceutics 2021;13:1067. [PMID: 34371758 DOI: 10.3390/pharmaceutics13071067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Afshari AR, Sanati M, Mollazadeh H, Kesharwani P, Johnston TP, Sahebkar A. Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways. Semin Cancer Biol 2022:S1044-579X(22)00018-9. [PMID: 35115226 DOI: 10.1016/j.semcancer.2022.01.008] [Reference Citation Analysis]
11 Lee D, Kwon S, Jang SY, Park E, Lee Y, Koo H. Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles. Bioact Mater 2022;8:20-34. [PMID: 34541384 DOI: 10.1016/j.bioactmat.2021.06.019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Yang X, Lai Q, Yang X, Xie B, Zhang B, Zhang X, Wei Y. Recent development and advances in the fabrication and biomedical applications of nanoparticle-based drug delivery systems for metformin. Mater Chem Front 2022;6:128-44. [DOI: 10.1039/d1qm01277k] [Reference Citation Analysis]
13 Hou X, Shou C, He M, Xu J, Cheng Y, Yuan Z, Lan M, Zhao Y, Yang Y, Chen X, Gao F. A combination of LightOn gene expression system and tumor microenvironment-responsive nanoparticle delivery system for targeted breast cancer therapy. Acta Pharm Sin B 2020;10:1741-53. [PMID: 33088693 DOI: 10.1016/j.apsb.2020.04.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]